Bioceres Crop Solutions Corp. · NASDAQ:BIOX
Bioceres Crop Solutions — Q1 2025 Earnings Presentation
15 slides from Bioceres Crop Solutions's earnings presentation, Nov 12, 2024
Slide 1: Fiscal First Quarter 2025
Fiscal First Quarter 2025 November / 2024
Slide 2: Disclaimer
BIOCERES CROP SOLUTIONS Disclaimer Industry and Market Data Unless otherwise noted, the forecasted industry and market data contained in the assumptions for the projections are based upon the Company’s management estimates For example, other companies may calculate non-IFRS measures differently, or
Slide 3: Key Business & Financial Highlights
BIOCERES CROP SOLUTIONS Key Business & Financial Highlights • Total revenues in 1Q25 were $93.3 million, compared to $116.6 million in the same quarter last year. Results impacted by performance in Argentina, where the summer crop season began at an unusually slow pace due to delayed rains and just-
Slide 4: 1Q25 Revenue by Segment
BIOCERES CROP SOLUTIONS 1Q25 Revenue by Segment ($ Million) 1Q24 1Q25 Reporting Segment Key Drivers by Segment Lower product use in Argentina primarily Crop due to dry weather. Protection Heightened competition and price pressure in third-party products. 116.6 93.3 - 20% Seed & Lower HB4 downstream
Slide 5: 1Q25 Gross Profit by Segment
BIOCERES CROP SOLUTIONS 1Q25 Gross Profit by Segment ($ Million) 1Q24 1Q25 Reporting Segment Key Drivers by Segment Gross profit decrease less than sales Crop due to product mix towards higher Protection profitability products with faster cash conversion. 45.0 37.5 - 17% Seed & Gross profit declined
Slide 6: 1Q25 Adjusted EBITDA
BIOCERES CROP SOLUTIONS 1Q25 1Q25 Adjusted ($ Million) EBITDA1 16.3 (1.1) (1.2) (5.4) (0.8) 2.7 8.5 (2.1) 1. Please refer to “Use of non-IFRS financial information” for information Adj. EBITDA1 Crop Crop Other income Adj. EBITDA1 S&IP OPEX2 JVs regarding net loss, operating profit and our use of Adj
Slide 7: Balance Sheet & Cash Position
BIOCERES CROP SOLUTIONS Balance Sheet 1Q24 ($ Million) 1Q25 & Cash Position ($ Million) ($ Million) Net Debt Net Debt 2.51x 2.88x Adj. EBITDA1 Adj. EBITDA1 250.2 226.4 128.7 125.7 1. Please refer to “Use of non-IFRS financial information” for information regarding net loss, operating profit and our
Slide 8: Award-winning Biological Platform for Pest Control
BIOCERES CROP SOLUTIONS Award-winning Biological Platform for Pest Control ProFarm receives EPA’s Green FROM TO Chemistry Challenge Award for Allows ~10x 200 – 400 ml/100kg 30 – 60 ml/100kg RinoTec Technology in the dose reduction Design of Safer and Degradable Chemicals category at seed treatment C
Slide 9: Full Clearance for HB4 Soy Cultivation Across the Americas
BIOCERES CROP SOLUTIONS Full Clearance for HB4 Soy Cultivation Across the Americas CAN I ~2.5M Ha Hectares under cultivation approval for GMO soybeans USA I ~34M Ha TECHNOLOGY HECTARES1 1° RR1 100.9M 2° HB4 100.4M BRA I ~39M Ha 3° INTACTA 100.4M 4° ENLIST 99.4M PAR I ~3.0M Ha BOL I ~1.0M Ha 5° CONKE
Slide 10: Looking Ahead
BIOCERES CROP SOLUTIONS Looking Ahead • Normalized rainfall in Argentina supports optimism for the remainder of the season • North America and Brazil gaining traction • Emphasis on cash generation • Strategy revision on HB4/seeds being finalized, with two main objectives: • Accelerating the transiti
Slide 11: Exhibits
Exhibits
Slide 12: Unaudited Consolidated Statement of Comprehensive Income
BIOCERES CROP SOLUTIONS Three-month period ended Three-month period ended 09/30/2024 09/30/2023 Unaudited Revenues from contracts with customers Initial recognition and changes in the fair value of biological assets at the point of harvest 92.6 0.7 116.2 0.4 Consolidated Cost of sales Gross profit (
Slide 13: Unaudited Consolidated Statement of Financial Position
BIOCERES CROP SOLUTIONS ASSETS 09/30/2024 06/30/2024 LIABILITIES 09/30/2024 06/30/2024 Unaudited CURRENT ASSETS Cash and cash equivalents 32.3 44.5 CURRENT LIABILITIES Trade and other payables 149.9 168.7 Borrowings 121.5 136.7 Consolidated Other financial assets Trade receivables 5.9 195.4 11.7 207
Slide 14: Non-IFRS Financial Measures
BIOCERES CROP SOLUTIONS Non-IFRS Financial Measures Adjusted EBITDA The company defines adjusted EBITDA as net income/(loss) exclusive of • Other companies may calculate adjusted EBITDA and similarly titled financial income/(costs), income tax benefit/(expense), depreciation, measures differently, l
Slide 15: Contact Us: Investor Relations
Contact Us: Investor Relations Investorrelations@biocerescrops.com // Investors.biocerescrops.com
Bioceres Crop Solutions — Q1 2025 Earnings Presentation on 6ix